XML 25 R15.htm IDEA: XBRL DOCUMENT v3.26.1
BUSINESS SEGMENT
3 Months Ended
Mar. 31, 2026
BUSINESS SEGMENT  
BUSINESS SEGMENT

9.    BUSINESS SEGMENT

The Company operates in a single reportable segment, referred to as safety medical syringes and other safety medical devices. The business is managed by the chief executive officer who is the Chief Operating Decision Maker (CODM). The CODM evaluates segment performance based on operating income (loss) for purposes of allocating resources and evaluating financial performance.  The accounting policies of our single reportable segment are the same as those for the Company as a whole.

The following are summaries of the Company’s sales and long-lived assets by geography:

Three Months Ended

Three Months Ended

  ​ ​ ​

March 31, 2026

  ​ ​ ​

March 31, 2025

U.S. sales

$

5,948,325

$

7,432,309

North and South America sales (excluding U.S.)

 

855,850

 

553,500

Other international sales

 

373,222

 

309,364

Total sales

$

7,177,397

$

8,295,173

Long-lived assets by geography are as follows:

  ​ ​ ​

March 31, 2026

  ​ ​ ​

December 31, 2025

Long-lived assets

U.S.

$

74,211,245

$

75,996,168

International

3,094,963

3,183,881

Total

$

77,306,208

$

79,180,049